Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Injective (INJ) vs Linea (LINEA) Price & Performance

InjectiveTrade
LineaTrade

Price performance (Past 24H)

Key statistics

Injective vs Linea — how do they compare? Injective trades at Rp93,833 (market cap Rp9,29T, Rp1,86T 24h volume), while Linea trades at Rp44.73 (market cap Rp1T, Rp221,52M 24h volume). The key difference: Injective is far larger — about 9.3× Linea's market cap, and Linea's supply is capped (22,3B / 72B LINEA (31%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and Linea for 25 Days on average.

INJLINEA
Market Cap
Rp9,29TRp1T
Volume (24h)
Rp1,86TRp221,52M
Circulating Supply
100M INJ22,3B / 72B LINEA (31%)
Typical Hold Time
36 Days25 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Injective

Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.

Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.

Linea

Linea trades at Rp44.748 with a market cap of Rp1 trillion, showing a bullish technical signal despite bearish moving averages. The token is in a consolidation phase near pivot point Rp45, with neutral oscillators suggesting balanced momentum. With 31% of max supply circulating and a 25-day average hold time, on-chain activity indicates moderate holder commitment. No major protocol upgrades or ecosystem news have been reported recently, keeping fundamental drivers subdued.

Overall outlook is cautiously optimistic given the bullish technical bias, but limited fundamental catalysts and crypto market volatility pose risks. Key opportunities include potential breakout above resistance Rp46, while major risks involve low liquidity depth and regulatory uncertainty. Investors should monitor trading volume trends and network adoption for directional cues.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INJ
29% Buy71% Sell
Avg holding period · 36 Days
LINEA
84% Buy16% Sell
Avg holding period · 25 Days

Top news

Latest headlines on both assets

About Injective

Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.

Read more on INJ

About Linea

Linea is a Layer 2 network built to strengthen Ethereum and its economy. With ETH burn mechanics, native yield, and Ethereum-equivalent zk tech, Linea enhances the value and utility of Ethereum Mainnet. Backed by the largest ecosystem fund and trusted Ethereum builders, Linea offers institutional-grade infrastructure and deep DeFi integration—making it the best chain for ETH capital.

Read more on LINEA